Please check the following:
- {{error.value}}
FREE membership
FREE membership
Join InvestSMART today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Start your free 15 day trial now' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
OR
Sign up with
Login with
By continuing, you agree to our
Log in
Your account has been locked.
Please contact our {{ isPMAUser ? 'Portfolio Services' : 'Customer Service' }} Team:
- Call 1300 880 160
Looks you are already a member. Please enter your password to proceed
OR
Sign up with
Login with
By continuing, you agree to our
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Your account has been locked.
Please contact our {{ isPMAUser ? 'Portfolio Services' : 'Customer Service' }} Team:
- Call 1300 880 160
OR
Sign up with
Login with
By continuing, you agree to our
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Check your inbox
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
Australian Clinical Labs Limited (ASX:ACL)
ALERT: Price-sensitive ASX Announcement for ACL
Current share price for ACL : $2.270 0.26 (12.94%)+
Announcement
Release
28 May 2026 9:06AM
Price at Release
$2.010
Full Release
Summary
Australian Clinical Labs Limited (ACL) announced the appointment of Greg Horan as its new Group CEO and Executive Director, effective August 31, 2026, following the departure of Melinda McGrath. Horan, who has extensive experience in the healthcare sector as the former CEO of Healthscope, will join ACL on June 1, 2026, in a transition role. His leadership is anticipated to guide ACL through its next growth phase, building on the strong foundation established by McGrath over the past decade. The announcement details Horan's remuneration package and eligibility for incentive plans.
Key Points
- Australian Clinical Labs (ACL) appointed Greg Horan as the new Group CEO and Executive Director.
- Greg Horan will join ACL on June 1, 2026, as Group CEO-elect and assume the full role on August 31, 2026.
- Current Group CEO Melinda McGrath will step down after ten years in the position.
- Greg Horan was previously CEO of Healthscope, leading 20,000 employees and 5,000 medical officers across 43 hospitals.
- Greg Horan has a background in mining and private equity, with 25 years of diverse industry experience.
- ACL Board Chair Stephen Roche praises Greg Horan's deep healthcare experience and leadership skills.
- Melinda McGrath is recognized for her decade of leadership and for building a resilient platform at ACL.
- Greg Horan's contract details include a base remuneration of $1,000,000 per annum plus superannuation.
- Greg Horan is eligible for participation in Short-Term and Long-Term Incentive Plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
